Unintended effects of statins: yellow card reports add data

Katherine Davidson; Sheena Kerr; Moira Kinnear; D Nicholas Bateman

doi:10.1136/bmj.c3697

Unintended effects of statins: yellow card reports add data

Katherine Davidson, Sheena Kerr, Moira Kinnear, D Nicholas Bateman

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Research output: Contribution to journal › Letter › peer-review

Abstract

Like Hippisley-Cox and Coupland,1 our retrospective study using yellow card data submitted to the Medicines and Healthcare products Regulatory Agency (MRHA) from 2002 to 2006 found that lipid lowering drugs are often reported in association with drug induced renal toxicity. They came third after recognised nephrotoxins such as non-steroidal anti-inflammatory drugs and drugs acting on the renin-angiotensin system and ahead of loop diuretics, potassium sparing diuretics, and aldosterone antagonists.

Original language	English
Article number	c3697
Journal	British Medical Journal
Volume	341
DOIs	https://doi.org/10.1136/bmj.c3697
Publication status	Published - 13 Jul 2010

Keywords

yellow card data
lipid lowering drugs
nephrotoxins
statins

Access to Document

10.1136/bmj.c3697

Cite this

@article{fb4805d101f34511bced44d5f1b3cd7f,

title = "Unintended effects of statins: yellow card reports add data",

abstract = "Like Hippisley-Cox and Coupland,1 our retrospective study using yellow card data submitted to the Medicines and Healthcare products Regulatory Agency (MRHA) from 2002 to 2006 found that lipid lowering drugs are often reported in association with drug induced renal toxicity. They came third after recognised nephrotoxins such as non-steroidal anti-inflammatory drugs and drugs acting on the renin-angiotensin system and ahead of loop diuretics, potassium sparing diuretics, and aldosterone antagonists.",

keywords = "yellow card data , lipid lowering drugs, nephrotoxins, statins",

author = "Katherine Davidson and Sheena Kerr and Moira Kinnear and Bateman, {D Nicholas}",

year = "2010",

month = jul,

day = "13",

doi = "10.1136/bmj.c3697",

language = "English",

volume = "341",

journal = "British Medical Journal",

issn = "0959-8138",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Unintended effects of statins

T2 - yellow card reports add data

AU - Davidson, Katherine

AU - Kerr, Sheena

AU - Kinnear, Moira

AU - Bateman, D Nicholas

PY - 2010/7/13

Y1 - 2010/7/13

N2 - Like Hippisley-Cox and Coupland,1 our retrospective study using yellow card data submitted to the Medicines and Healthcare products Regulatory Agency (MRHA) from 2002 to 2006 found that lipid lowering drugs are often reported in association with drug induced renal toxicity. They came third after recognised nephrotoxins such as non-steroidal anti-inflammatory drugs and drugs acting on the renin-angiotensin system and ahead of loop diuretics, potassium sparing diuretics, and aldosterone antagonists.

AB - Like Hippisley-Cox and Coupland,1 our retrospective study using yellow card data submitted to the Medicines and Healthcare products Regulatory Agency (MRHA) from 2002 to 2006 found that lipid lowering drugs are often reported in association with drug induced renal toxicity. They came third after recognised nephrotoxins such as non-steroidal anti-inflammatory drugs and drugs acting on the renin-angiotensin system and ahead of loop diuretics, potassium sparing diuretics, and aldosterone antagonists.

KW - yellow card data

KW - lipid lowering drugs

KW - nephrotoxins

KW - statins

U2 - 10.1136/bmj.c3697

DO - 10.1136/bmj.c3697

M3 - Letter

C2 - 20627983

SN - 0959-8138

VL - 341

JO - British Medical Journal

JF - British Medical Journal

M1 - c3697

ER -

Unintended effects of statins: yellow card reports add data

Abstract

Keywords

Access to Document

Fingerprint

Cite this